Trading since 2002, Conidia Bioscience develops, manufactures and sells FUELSTAT® fuel tests into the aviation, marine and land diesel sectors. Our suite of tests detects microbiological contaminat...
Trading since 2002, Conidia Bioscience develops, manufactures and sells FUELSTAT® fuel tests into the aviation, marine and land diesel sectors. Our suite of tests detects microbiological contamination, using a test that is fast and easy to use, and which gives results in minutes. The tests were initially developed as a part of the non-profit international intergovernmental research and publishing organisation CABI, but are now widely and commercially available. FUELSTAT®, Conidia's internationally patented intellectual property based on immunoassay technology, was first presented in the form of a rapid test for jet fuel fungus for the aviation industry. Its adoption was rapid, given the highly regulated and conservative nature of the industry. The product's credibility is enhanced by IATA recommendation and inclusion in the Boeing, Airbus, Embraer, BAE Systems, Fokker and Raytheon maintenance manuals. The kit is currently regularly purchased by over 300 airlines and aircraft maintenance organisations around the world with sales still growing rapidly, every year. As a major shareholder, CABI shares its extensive facilities with Conidia Bioscience Ltd, including its impressively resourced, UKAS accredited laboratory facility. Dr Joan Kelley, inventor and Technical Director of both CABI and Conidia, manages and orchestrates the extensive Conidia Bioscience R&D programme. Other Conidia Bioscience shareholders include two corporate investors and an Austrian life science strategic partner, Biomedica Group, which is actively involved in Conidia Bioscience's R&D and production.